Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
32,877
Sort by:
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris - Drugs In Development, 2021...
September 2021
88 pages
Peritonitis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Peritonitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Drugs In Development, 2021, provid...
September 2021
53 pages
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021
US$ 2,000.00
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinocerebellar Ataxia - Drugs In Development, 202...
September 2021
113 pages
Tularaemia (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Tularaemia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia - Drugs In Development, 2021, provid...
September 2021
44 pages
NRT Smoking Cessation Aids in Egypt
US$ 990.00
... run campaigns to discourage smoking, and NRT smoking cessation aids are prohibited in the country. Some brands are available, however,... Euromonitor International's NRT Smoking Cessation Aids in Egypt report offers a comprehensive ...
September 2021
16 pages
U.K. Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (Contract Outsourcing, In-house), By Product Life Cycle, By Type, By Process Flow, By Therapeutic Area, By End-use, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
This report can be delivered to the clients within Immediate U.K. Pharmacovigilance Market Growth & Trends The U.K. pharmacovigilance market size is expected to reach USD 510.37 million by 2028, acc...
September 2021
186 pages
High Potency Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Product (Synthetic, Biotech), By Manufacturer Type (In-house, Outsourced), By Drug Type, By Application, By Region, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
... India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period. In addition, supportive ... show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development Oncology segment ...
September 2021
140 pages
Synthetic Vitamin E - A Global Market Overview
US$ 3,600.00
... .2 million. RESEARCH FINDINGS & COVERAGE Synthetic Vitamin E market is analyzed in this report ... Synthetic Vitamin E by a major geographic region Installed capacities of Synthetic Vitamin E manufacturers Supply Shortage of Vitamin E Spikes Prices Forcing Feed Manufacturers to Reduce the Usage Synthetic Vitamin ...
September 2021
192 pages
Research Report on China's Alectinib Market, 2021-2025
US$ 2,600.00
Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 4.57 million new cancer cases were reported in China in 2020, including 820,000 lung cancer cases. 3 million cance...
September 2021
40 pages
Research Report on China's Anastrozole Market, 2021-2025
US$ 2,600.00
According to IARC’s 2020 World Cancer Report, the number of new cases of breast cancer reached 2.26 million in 2020, larger than that of lung cancer cases which was 2.2 million. Breast cancer has beco...
September 2021
40 pages
Research Report on China's Escitalopram Market, 2021-2025
US$ 2,600.00
Depression is the fourth leading disease in the world and is expected to become the first by 2030. However, the medical prevention and treatment of depression in China is still of low recognition rate...
September 2021
40 pages
Research Report on China's Exemestane Market, 2021-2025
US$ 2,600.00
Breast cancer is a common malignant tumor in menopausal women, and now ranks first among malignant tumors in women. Recently, the number of breast cancer patients in China has been increasing year by...
September 2021
40 pages
Research Report on China's Gefitinib Market, 2021-2025
US$ 2,600.00
Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 19.29 million new cancer cases were diagnosed worldwide in 2020, 4.57 million of which were in China, accounting f...
September 2021
40 pages
Research Report on China's Levetiracetam Market, 2021-2025
US$ 2,600.00
Epilepsy is second only to stroke as a common chronic neurological disorder characterized by excessive neuronal discharge in the brain resulting in recurrent, seizure and transient central nervous sys...
September 2021
40 pages
Research Report on China's Lobaplatin Market, 2021-2025
US$ 2,600.00
According to IARC of WHO, globally, there were 19.29 million new cases of cancer in 2020, among which 2.26 million were cases of breast cancer, surpassing the 2.2 million cases of lung cancer. Breast...
September 2021
40 pages
Research Report on China's Mesalazine Market, 2021-2025
US$ 2,600.00
Inflammatory bowel disease (IBD) is a chronic disease of the digestive system with unclear etiology, difficulty to cure, and recurrent attacks with multiple complications. The incidence of IBD in Chin...
September 2021
40 pages
Research Report on China's Roxatidine Market, 2021-2025
US$ 2,600.00
Peptic ulcers and gastrointestinal bleeding are common diseases in China with a large number of patients. Due to the fast pace of modern life, accelerated urbanization and great mental stress, the num...
September 2021
40 pages
Research Report on China's Sorafenib Market, 2021-2025
US$ 2,600.00
Hepatocellular carcinoma (HCC) is the most common type of chronic liver cancer in adults and the most common cause of death in patients with cirrhosis. Hepatocellular carcinoma (HCC) is the third most...
September 2021
40 pages
Research Report on China's Venlafaxine Market, 2021-2025
US$ 2,600.00
Depression is the result of a complex interplay of social, psychological and physical factors. People who experience adverse events in their lives are more likely to develop depression. Depression can...
September 2021
40 pages
Research Report on China's Zoledronic Acid Market, 2021-2025
US$ 2,600.00
Osteoporosis is a metabolic disease caused by a combination of endocrine, nutritional, immune, and genetic factors, and is characterized by increasing bone fragility and fracture due to a gradual decr...
September 2021
40 pages
Protein Characterization and Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectrometry), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery), End User (Pharma, Biotech, CROs) - Global Forecast to 2026
US$ 4,950.00
... the Marketing Automation Software market is the need of marketing accountability, third-party application ecosystem, and growth in multiple online channels is enhancing the market globally ... report will help the market leaders/new entrants in this market in the following ways: 1. This report segments the market into application types ...
September 2021
334 pages
Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2021 - 2028
US$ 5,950.00
The global viscosupplementation market size is expected to reach USD 7.1 billion by 2026 ... to the prolonged presence and holding a significant market share Single injection segment is anticipated to be one ... pain Geographically, Asia Pacific held the largest market share in 2018 and is expected to maintain ...
September 2021
145 pages
Critical Limb Ischemia - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Critical Limb Ischemia The report also ...
September 2021
60 pages
Hepatitis A - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Hepatitis A - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatitis A development. The report provides ...
September 2021
60 pages
Leber hereditary optic neuropathy - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Leber's Hereditary Optic Neuropathy The report also ...
September 2021
60 pages
Cyclin-dependent-kinase-inhibitors - Pipeline Insight, 2021
US$ 2,500.00
... (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “Cyclin-Dependent Kinase Inhibitor The report ...
September 2021
150 pages
Chronic lymphocytic leukemia - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 5-7 business days DelveInsight’s, “Chronic lymphocytic leukemia – Pipeline Insight, 2021,” report provides comprehensive insights about 60+ compani...
September 2021
120 pages
Central Nervous System Lymphoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Central Nervous System Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights about 13+ companies...
September 2021
60 pages
Central Serous Chorioretinopathy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Central Serous Chorioretinopathy – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...
September 2021
60 pages
E-Pharmacy Market in India 2021
US$ 950.00
In the recent years, e-pharmacy emerged as a better and more convenient approach that addressed the issues faced by the consumers and provided superior customer solutions over its physical counterpart...
September 2021
76 pages
Spinal Cord Injury - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Spinal Cord Injury - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline...
September 2021
80 pages
Advanced Cervical Cancer - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Advanced Cervical Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies a...
September 2021
60 pages
Advanced Endometrial Cancer - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Advanced Endometrial Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companie...
September 2021
60 pages
Advanced Gastric Carcinoma - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Advanced Gastric Carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies...
September 2021
60 pages
